Creative Planning Invests $255,000 in National Research Co. (NRCIB)

Creative Planning bought a new position in shares of National Research Co. (NASDAQ:NRCIB) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 4,551 shares of the business services provider’s stock, valued at approximately $255,000.

Other hedge funds have also made changes to their positions in the company. Schwab Charles Investment Management Inc. bought a new stake in shares of National Research during the third quarter worth $215,000. California Public Employees Retirement System bought a new stake in shares of National Research during the second quarter worth $224,000. Finally, Tudor Investment Corp ET AL bought a new stake in shares of National Research during the second quarter worth $243,000. Institutional investors own 2.21% of the company’s stock.

National Research Co. (NASDAQ NRCIB) opened at $56.40 on Tuesday. The stock has a market capitalization of $199.67, a PE ratio of 18.31 and a beta of 0.09. National Research Co. has a 1-year low of $38.76 and a 1-year high of $58.16.

National Research (NASDAQ:NRCIB) last posted its quarterly earnings results on Tuesday, November 7th. The business services provider reported $0.09 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.23 by ($0.14). National Research had a net margin of 19.09% and a return on equity of 30.84%.

The company also recently declared a quarterly dividend, which was paid on Friday, January 12th. Investors of record on Friday, December 29th were issued a $0.60 dividend. This represents a $2.40 annualized dividend and a yield of 4.26%. The ex-dividend date of this dividend was Thursday, December 28th. National Research’s dividend payout ratio is 77.92%.

WARNING: This report was first posted by Stock Observer and is owned by of Stock Observer. If you are reading this report on another website, it was copied illegally and reposted in violation of US & international copyright and trademark law. The original version of this report can be accessed at

National Research Company Profile

National Research Corporation provides analytics and insights for the patient and employee experience in serving the healthcare providers, payers, and other healthcare organizations in the United States and Canada. Its portfolio of subscription-based solutions offer information and analysis services in a range of elements, including patient experience and satisfaction, community population health risks, workforce engagement, community perceptions, and physician engagement.

Want to see what other hedge funds are holding NRCIB? Visit to get the latest 13F filings and insider trades for National Research Co. (NASDAQ:NRCIB).

Institutional Ownership by Quarter for National Research (NASDAQ:NRCIB)

Receive News & Ratings for National Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research and related companies with's FREE daily email newsletter.

Leave a Reply